EXCEED THE SPACE PROVIDED. Microbes responsible for infectious disease outbreaks – from either natural, e.g., multidrug-resistant Staphylococcus aureus, or bioterrorism, e.g.,anthrax, causes – are typically virulent forms of a single species.
Population genomics, which is the study of intraspecific variations of a single microbial species, is therefore a key to uncovering virulence factors and disease-causing mechanisms, as well as tracking the sources of microbial disease. The Evolutionary Informatics Lab at Hunter College is a vital partner in a multi- institutional team of comparative genomics of Borrelia burgdorferi, the Lyme disease agent.
We are responsible for the bioinformatics system development and evolutionary statistical analysis, including experimental design, data processing and warehousing, and evolutionary analysis. Through evolutionary statistical analysis our lab discovered a surprisingly high amount of genetic exchange and plasmid transfer in B.
burgdorferi. To continue our success in characterizing the population structure of pathogenic bacteria based on comparative genomics, I propose a 5-years project to develop a bioinformatics infrastructure dedicated to the analysis of population variations of pathogenic microbes. We have two specific aims in this proposal.
MART-1 / Melan-A(M2-7C10), 0.2mg/mL |
BNUB0009-100 |
Biotium |
100uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10), 0.2mg/mL |
BNUB0009-500 |
Biotium |
500uL |
EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10) Antibody |
BNCH0009-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNCH0009-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNC700009-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), CF770 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNC700009-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), CF770 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNC800009-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), CF680 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNC800009-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), CF680 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNC810009-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), CF680R conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNC810009-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), CF680R conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNC550009-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), CF555 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNC550009-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), CF555 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNC610009-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), CF660R conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNC610009-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), CF660R conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNC430009-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), CF543 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNC430009-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), CF543 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNC050009-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), CF405M conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNC050009-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), CF405M conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNCA0009-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), APC conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNCAP0009-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNCAP0009-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNCP0009-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), PerCP conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10) Antibody |
BNCR0009-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10), RPE conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3), 1mg/mL |
BNUM0705-50 |
Biotium |
50uL |
EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3), 0.2mg/mL |
BNUB0705-100 |
Biotium |
100uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3), 0.2mg/mL |
BNUB0705-500 |
Biotium |
500uL |
EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNCH0705-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNCH0705-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNC700705-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF770 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNC700705-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF770 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNC810705-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF680R conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNC810705-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF680R conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNC800705-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF680 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNC800705-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF680 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNC550705-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF555 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNC550705-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF555 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNC430705-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF543 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNC430705-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF543 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNC610705-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF660R conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNC610705-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF660R conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNC050705-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF405M conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNC050705-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), CF405M conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNCA0705-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), APC conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNCAP0705-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNCAP0705-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNCP0705-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), PerCP conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3) Antibody |
BNCR0705-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3), RPE conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), 1mg/mL |
BNUM0700-50 |
Biotium |
50uL |
EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), 0.2mg/mL |
BNUB0700-100 |
Biotium |
100uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), 0.2mg/mL |
BNUB0700-500 |
Biotium |
500uL |
EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10), CF594 conjugate, 0.1mg/mL |
BNC940009-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10), CF594 conjugate, 0.1mg/mL |
BNC940009-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNCH0700-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNCH0700-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MART-1; Clones M2-7C10 & M2-9E3 (Ready-To-Use) |
A00133-0025 |
ScyTek Laboratories |
25 ml |
EUR 235.27 |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNC700700-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF770 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNC700700-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF770 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNC810700-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF680R conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNC810700-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF680R conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNC800700-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF680 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNC800700-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF680 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNC550700-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF555 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNC550700-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF555 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNC430700-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF543 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNC430700-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF543 conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNC610700-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF660R conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNC610700-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF660R conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10), CF647 conjugate, 0.1mg/mL |
BNC470009-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10), CF647 conjugate, 0.1mg/mL |
BNC470009-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10), CF568 conjugate, 0.1mg/mL |
BNC680009-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10), CF568 conjugate, 0.1mg/mL |
BNC680009-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNC050700-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF405M conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNC050700-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF405M conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNCA0700-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), APC conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNCAP0700-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNCAP0700-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNCP0700-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), PerCP conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103) Antibody |
BNCR0700-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), RPE conjugate, Concentration: 0.1mg/mL |
MART-1 / Melan-A(M2-7C10), CF488A conjugate, 0.1mg/mL |
BNC880009-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10), CF488A conjugate, 0.1mg/mL |
BNC880009-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10), CF640R conjugate, 0.1mg/mL |
BNC400009-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10), CF640R conjugate, 0.1mg/mL |
BNC400009-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10), CF405S conjugate, 0.1mg/mL |
BNC040009-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10), CF405S conjugate, 0.1mg/mL |
BNC040009-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10), Biotin conjugate, 0.1mg/mL |
BNCB0009-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10), Biotin conjugate, 0.1mg/mL |
BNCB0009-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Apolipoprotein A-1 Expressing Stable MC38 Cell Line (MC38 Apo) |
T3219 |
ABM |
1x10^6 cells / 1.0 ml |
Ask for price |
Recombinant Escherichia coli aaeX Protein (aa 1-67) (strain K12 / MC4100 / BW2952) |
VAng-Lsx02148-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) Protein AaeX, recombinant protein. |
Recombinant Escherichia coli crcB Protein (aa 1-127) (strain K12 / MC4100 / BW2952) |
VAng-Lsx02248-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) Protein CrcB homolog, recombinant protein. |
Recombinant Escherichia coli cysZ Protein (aa 1-253) (strain K12 / MC4100 / BW2952) |
VAng-Lsx02285-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) Protein CysZ, recombinant protein. |
Recombinant Escherichia coli dapB Protein (aa 1-273) (strain K12 / MC4100 / BW2952) |
VAng-Lsx02309-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 4728 |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) Dihydrodipicolinate reductase, recombinant protein. |
Recombinant Escherichia coli dapB Protein (aa 1-273) (strain K12 / MC4100 / BW2952) |
VAng-Lsx02309-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 3342 |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) Dihydrodipicolinate reductase, recombinant protein. |
Recombinant Escherichia coli dapB Protein (aa 1-273) (strain K12 / MC4100 / BW2952) |
VAng-Lsx02309-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 2287.2 |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) Dihydrodipicolinate reductase, recombinant protein. |
Recombinant Escherichia coli dapD Protein (aa 1-274) (strain K12 / MC4100 / BW2952) |
VAng-Lsx02331-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 4728 |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase, recombinant protein. |
Recombinant Escherichia coli dapD Protein (aa 1-274) (strain K12 / MC4100 / BW2952) |
VAng-Lsx02331-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 3360 |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase, recombinant protein. |
Recombinant Escherichia coli dapD Protein (aa 1-274) (strain K12 / MC4100 / BW2952) |
VAng-Lsx02331-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 2287.2 |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase, recombinant protein. |
Recombinant Escherichia coli psiE Protein (aa 1-136) (strain K12 / MC4100 / BW2952) |
VAng-Lsx02581-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) Protein psiE, recombinant protein. |
Recombinant Escherichia coli uspB Protein (aa 1-111) (strain K12 / MC4100 / BW2952) |
VAng-Lsx02696-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) Universal stress protein B, recombinant protein. |
Recombinant Escherichia coli yeaL Protein (aa 1-148) (strain K12 / MC4100 / BW2952) |
VAng-Lsx02799-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) UPF0756 membrane protein YeaL, recombinant protein. |
Recombinant Escherichia coli yjjB Protein (aa 1-157) (strain K12 / MC4100 / BW2952) |
VAng-Lsx02930-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) UPF0442 protein yjjB, recombinant protein. |
Recombinant Escherichia coli yqhA Protein (aa 1-164) (strain K12 / MC4100 / BW2952) |
VAng-Lsx02995-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) UPF0114 protein YqhA, recombinant protein. |
Recombinant Escherichia coli zntB Protein (aa 1-327) (strain K12 / MC4100 / BW2952) |
VAng-Lsx03032-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) Zinc transport protein ZntB, recombinant protein. |
Recombinant Escherichia coli zupT Protein (aa 1-257) (strain K12 / MC4100 / BW2952) |
VAng-Lsx03046-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Escherichia coli (strain K12 / MC4100 / BW2952) Zinc transporter ZupT, recombinant protein. |
CEA-1 Stable MC-38 Cell Line |
T6407 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
MART-1 / Melan-A(M2-7C10 + M2-9E3), CF594 conjugate, 0.1mg/mL |
BNC940705-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3), CF594 conjugate, 0.1mg/mL |
BNC940705-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3), CF647 conjugate, 0.1mg/mL |
BNC470705-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3), CF647 conjugate, 0.1mg/mL |
BNC470705-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3), CF568 conjugate, 0.1mg/mL |
BNC680705-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3), CF568 conjugate, 0.1mg/mL |
BNC680705-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3), CF488A conjugate, 0.1mg/mL |
BNC880705-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3), CF488A conjugate, 0.1mg/mL |
BNC880705-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3), CF405S conjugate, 0.1mg/mL |
BNC040705-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3), CF405S conjugate, 0.1mg/mL |
BNC040705-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3), CF640R conjugate, 0.1mg/mL |
BNC400705-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3), CF640R conjugate, 0.1mg/mL |
BNC400705-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3), Biotin conjugate, 0.1mg/mL |
BNCB0705-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3), Biotin conjugate, 0.1mg/mL |
BNCB0705-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF594 conjugate, 0.1mg/mL |
BNC940700-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF594 conjugate, 0.1mg/mL |
BNC940700-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF647 conjugate, 0.1mg/mL |
BNC470700-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF647 conjugate, 0.1mg/mL |
BNC470700-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF568 conjugate, 0.1mg/mL |
BNC680700-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF568 conjugate, 0.1mg/mL |
BNC680700-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF488A conjugate, 0.1mg/mL |
BNC880700-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF488A conjugate, 0.1mg/mL |
BNC880700-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF405S conjugate, 0.1mg/mL |
BNC040700-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF405S conjugate, 0.1mg/mL |
BNC040700-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF640R conjugate, 0.1mg/mL |
BNC400700-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), CF640R conjugate, 0.1mg/mL |
BNC400700-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), Biotin conjugate, 0.1mg/mL |
BNCB0700-100 |
Biotium |
100uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A(M2-7C10 + M2-9E3 + A103), Biotin conjugate, 0.1mg/mL |
BNCB0700-500 |
Biotium |
500uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MART-1 / Melan-A / MLANA (Melanoma Marker); Clone M2-7C10 (Concentrate) |
RA0112-C.1 |
ScyTek Laboratories |
0.1 ml |
EUR 60.07 |
MART-1 / Melan-A / MLANA (Melanoma Marker); Clone M2-7C10 (Concentrate) |
RA0112-C.5 |
ScyTek Laboratories |
0.5 ml |
EUR 200.66 |
MC1568 |
27761-1 |
BPS Bioscience |
10 mg |
EUR 140 |
Description: Selective inhibitor of class IIa histone deacetylases (HDACs). Exhibits tissue-selective inhibition between members of class II deacetylases in vivo; inhibits HDAC4 and HDAC5 in skeletal muscle and the heart without affecting HDAC3 activity. Displays no inhibition of class I HDAC activity (HDAC1, 2, 3) or expression. |
MC1568 |
27761-2 |
BPS Bioscience |
25 mg |
EUR 195 |
Description: Selective inhibitor of class IIa histone deacetylases (HDACs). Exhibits tissue-selective inhibition between members of class II deacetylases in vivo; inhibits HDAC4 and HDAC5 in skeletal muscle and the heart without affecting HDAC3 activity. Displays no inhibition of class I HDAC activity (HDAC1, 2, 3) or expression. |
MC1568 |
E1KS1484 |
EnoGene |
5mg |
EUR 302.4 |
MC1568 |
A4094-10 |
ApexBio |
10 mg |
EUR 40 |
|
Description: Class II HDAC inhibitor,potent and selective |
MC1568 |
A4094-25 |
ApexBio |
25 mg |
EUR 80 |
|
Description: Class II HDAC inhibitor,potent and selective |
MC1568 |
A4094-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 44 |
|
Description: Class II HDAC inhibitor,potent and selective |
MC1568 |
A4094-S |
ApexBio |
Evaluation Sample |
EUR 22 |
|
Description: Class II HDAC inhibitor,potent and selective |
First, we will develop a novel statistical framework – non-housekeeping multilocus sequencing typing (NH-MLST) – of analyzing the bacterial intraspecific variations in a phylogenetic context, with the goal of detecting genes responsible for adaptive evolution in bacteria. Second, we will develop a computational infrastructure dedicated to the comparative genomics of closely related bacteria.
As comparative microbial sequencing becomes a standard approach for discovering virulence factors and tracing microbial outbreaks, the proposed project will provide a robust evolutionary analytical framework and an efficient computational system for comparative microbial genomics.